Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Finasteride reduces alcohol withdrawal effects, especially in female mice.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Gender affects the symptoms and severity of systemic lupus erythematosus.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Kids with vitiligo, psoriasis, or alopecia areata are more likely to experience anxiety, depression, and social challenges.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.